news
ABPI finds £377 million spent on UK R&D
The ABPI has reported findings from its transparency initiative, Disclosure UK, stating that R&D investment grew significantly from 2017 to 2018.
List view / Grid view
Drug Markets
news
Former FDA Commissioner joins Pfizer’s board of directors
Former FDA Commissioner, Scott Gottlieb, who stepped down from the administration in April, has joined Pfizer’s board of directors.
news
EMA releases medicinal approval recommendations
The EMA has given its approval recommendation to three drugs and announced negative opinions for approval on others.
news
AbbVie is to acquire Allergan in a ‘transformative transaction’
AbbVie Inc. and Allergan plc have entered into a definitive transaction agreement under which AbbVie will acquire Allergan.
news
GSK reported to have started the sale of $1.2 billion consumer health drugs
According to Reuters, GSK has started the sale of some consumer health brands as it seeks to raise £1 billion.
news
Global diabetes drug market expected to rise 3.6 percent
A new report predicts that the global diabetes drug market will rise to US$58.4 billion by 2025.
news
China announces generic drug list to reduce pharmaceutical costs
Chinese government introduces initiative to enable generic drugs to enter market and reduce prices.
news
FDA announces new data points to aid generic drug developers
The FDA has released new data points which increase transparency for generic-drug competitors.
news
Lynparza has been approved for BRCA-mutated advanced ovarian cancer
BRCA-mutated advanced ovarian cancer treatment has been approved by the European Commission.
news
Four pharmaceutical companies accused of illegal anti-competitive conduct
The CMA has revealed findings that provisionally show that four pharmaceutical companies have broken the law.
news
Biopharmaceutical contract manufacturing market expected to rise 10.6 percent
A study has predicted that the global biopharmaceutical contract manufacturing market will grow by 10.6 percent from 2017 to 2027.
news
US-China trade war leaves gap for Indian pharma to grow
A data analyst has reported that the current US-China trade war will give India chance to increase their pharmaceutical presence.
news
US Food and Drug Administration sued over Ruzurgi drug approval
Catalyst Pharmaceuticals Inc has sued the FDA to challenge the recent approval of a lower-cost rival drug.
news
Pharmaceutical packaging/labelling market to increase 5.3 percent
A new report predicts that the packaging and labelling industry for pharmaceutical products will increase by 5.3 percent.
news
FDA dermatology advisors found to accept payments after drug approvals
A study has shown that the majority of dermatology advisors to the FDA took payments subsequent to drug approvals.
